{
    "SPADE_UN_00769": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_00769",
            "Peptide Name": "a8 (IG-19 analogs)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ILKLFKRIVKRILKFLRKL",
            "Sequence Length": 19,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.22521196] Gram-positive bacteria :Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=8 μM);Gram-negative bacteria :Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=8 μM)",
            "Hemolytic Activity": "[Ref.22521196] MHC10=1.6 μM against human red blood cells",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "All of the peptides exhibited a predominantly-helical structure characterized by double minima at 208 and 222 nm in the presence of LPS.",
            "Formula": "C119H213N33O20",
            "Mass": 2426.17,
            "PI": 12.0,
            "Net Charge": 8,
            "Hydrophobicity": 0.49,
            "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria",
            "Literature": [
                {
                    "Title": "Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.",
                    "Pubmed ID": "22521196",
                    "Reference": "Peptides. 2012 Jun;35(2)239-247.",
                    "Author": "Nan YH, Bang JK, Jacob B, Park IS, Shin SY.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22521196"
                }
            ],
            "Frequent Amino Acids": "KLI",
            "Absent Amino Acids": "ACDEGHMNOPQSTUWY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 9,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08557",
                    "Similarity": 1.0,
                    "Sequence": "KLFKRIVKRILKFLRKLV"
                },
                {
                    "SPADE_ID": "SPADE_UN_18137",
                    "Similarity": 1.0,
                    "Sequence": "MMFSGPQILKL"
                },
                {
                    "SPADE_ID": "SPADE_UN_29653",
                    "Similarity": 1.0,
                    "Sequence": "KLFKRIVKRILKFLRKLV"
                }
            ]
        }
    }
}